Publication | Closed Access

S632A3, a new glutarimide antibiotic, suppresses lipopolysaccharide-induced pro-inflammatory responses via inhibiting the activation of glycogen synthase kinase 3β

InflammationNew GlutarimideGlycogen SynthaseLipopolysaccharide-induced Pro-inflammatory ResponsesAnti-inflammatoryBiochemistryMedicineAntimicrobial ChemotherapyMicrobiologyPharmacologyGlycosylation